Literature DB >> 20521763

Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors.

Sandeep Shrivastava1, Thomas J Pucadyil, Yamuna Devi Paila, Sourav Ganguly, Amitabha Chattopadhyay.   

Abstract

Statins are potent inhibitors of HMG-CoA reductase, the key rate-limiting enzyme in cholesterol biosynthesis, and are some of the best selling drugs globally. We have explored the effect of chronic cholesterol depletion induced by mevastatin on the function of human serotonin(1A) receptors expressed in CHO cells. An advantage with statins is that cholesterol depletion is chronic which mimics physiological conditions. Our results show a significant reduction in the level of specific ligand binding and G-protein coupling to serotonin(1A) receptors upon chronic cholesterol depletion, although the membrane receptor level is not reduced at all. Interestingly, replenishment of mevastatin-treated cells with cholesterol resulted in the recovery of specific ligand binding and G-protein coupling. Treatment of cells expressing serotonin(1A) receptors with mevastatin led to a decrease in the diffusion coefficient and an increase in the mobile fraction of the receptor, as determined by fluorescence recovery after photobleaching measurements. To the best of our knowledge, these results constitute the first report describing the effect of chronic cholesterol depletion on the organization and function of a G-protein-coupled neuronal receptor. Our results assume significance in view of recent reports highlighting the symptoms of anxiety and depression in humans upon statin administration, and the role of serotonin(1A) receptors in anxiety and depression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20521763     DOI: 10.1021/bi100276b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Stereospecific requirement of cholesterol in the function of the serotonin1A receptor.

Authors:  Md Jafurulla; Bhagyashree D Rao; Sugunan Sreedevi; Jean-Marie Ruysschaert; Douglas F Covey; Amitabha Chattopadhyay
Journal:  Biochim Biophys Acta       Date:  2013-09-02

2.  Initiation of statin therapy after acute myocardial infarction is not associated with worsening depressive symptoms: insights from the Prospective Registry Evaluating Outcomes After Myocardial Infarctions: Events and Recovery (PREMIER) and Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) registries.

Authors:  Firas J Al Badarin; John A Spertus; Kensey L Gosch; Donna M Buchanan; Paul S Chan
Journal:  Am Heart J       Date:  2013-10-09       Impact factor: 4.749

3.  The Functional Activity of the Human Serotonin 5-HT1A Receptor Is Controlled by Lipid Bilayer Composition.

Authors:  M Gertrude Gutierrez; Kylee S Mansfield; Noah Malmstadt
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

4.  Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling.

Authors:  Sergio Oddi; Enrico Dainese; Simone Sandiford; Filomena Fezza; Mirko Lanuti; Valerio Chiurchiù; Antonio Totaro; Giuseppina Catanzaro; Daniela Barcaroli; Vincenzo De Laurenzi; Diego Centonze; Somnath Mukhopadhyay; Jana Selent; Allyn C Howlett; Mauro Maccarrone
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Statins Perturb Gβγ Signaling and Cell Behavior in a Gγ Subtype Dependent Manner.

Authors:  Mithila Tennakoon; Dinesh Kankanamge; Kanishka Senarath; Zehra Fasih; Ajith Karunarathne
Journal:  Mol Pharmacol       Date:  2019-02-14       Impact factor: 4.436

6.  Depressive symptoms and serum lipid levels in young adult women.

Authors:  Carolyn Y Fang; Brian L Egleston; Kelley Pettee Gabriel; Victor J Stevens; Peter O Kwiterovich; Linda G Snetselaar; Margaret L Longacre; Joanne F Dorgan
Journal:  J Behav Med       Date:  2012-03-02

7.  Decreased cerebral spinal fluid neurotransmitter levels in Smith-Lemli-Opitz syndrome.

Authors:  S E Sparks; C A Wassif; H Goodwin; S K Conley; D C Lanham; L E Kratz; K Hyland; A Gropman; E Tierney; F D Porter
Journal:  J Inherit Metab Dis       Date:  2014-02-06       Impact factor: 4.982

Review 8.  Oxidative stress as a possible mechanism of statin-induced myopathy.

Authors:  Yasin Ahmadi; Amir Ghorbanihaghjo; Mohsen Naghi-Zadeh; Neda Lotfi Yagin
Journal:  Inflammopharmacology       Date:  2018-03-24       Impact factor: 4.473

Review 9.  Functional marriage in plasma membrane: Critical cholesterol level-optimal protein activity.

Authors:  Ulises Meza; Mayra Delgado-Ramírez; Catalina Romero-Méndez; Sergio Sánchez-Armass; Aldo A Rodríguez-Menchaca
Journal:  Br J Pharmacol       Date:  2020-03-24       Impact factor: 8.739

Review 10.  Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors:  Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.